IMCR - Company ID 0001671927
The table below shows Immunocore Holdings plc's balance sheet line items across its last 3 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Cash & equivalents | $467.71M | $455.73M | $442.63M |
| Short-term investments | $396.44M | $364.64M | - |
| Receivables | - | $63.01M | $52.09M |
| Inventory | $6.74M | $5.45M | $4.50M |
| Total current assets | $996.74M | $929.86M | $528.82M |
| Property, plant & equipment | $11.46M | $10.09M | $9.21M |
| Goodwill | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total assets |
| $1.07B |
| $1.01B |
| $597.00M |
| Accounts payable | $24.36M | $25.10M | $17.80M |
| Total current liabilities | $246.70M | $212.18M | $139.02M |
| Long-term debt | - | - | - |
| Total liabilities | $686.24M | $648.79M | $228.16M |
| Retained earnings | -$831.27M | -$795.76M | -$744.67M |
| Total equity | $381.03M | $360.72M | $368.84M |